In Mexico, the research & development by business enterprise, pharmaceutical industry in current ppp $ is now 112.22 million, representing a decrease of 14.50 million (-11.4%) since 2016.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Mexico
No matching regions
Similar regions to Mexico
Business R&D pharmaceutical in current PPP $
More indicators for Mexico
Government R&D in security as % of government support
0.21%
-0%
(2021)
Higher-education-finacing R&D financed by general university in local currency
162,658.59M
-15,512.20M
(2017)
R&D financed by rest of the world in local currency
6,133.93M
+516.67M
(2017)
Government R&D financed by rest of the world in local currency
1,434.36M
+120.82M
(2017)
Business R&D financed by rest of the world in local currency
2,452.44M
+206.57M
(2017)
Non-profit R&D growth rate
-3.9%
-1.86%
(2017)
Mexico Business R&D pharmaceutical in current PPP $ between 1994 and 2017
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2017 | 112.22M | -14.50M |
| 2016 | 126.71M | -3.14M |
| 2015 | 129.86M | +9.60M |
| 2014 | 120.26M | -50.37M |
| 2013 | 170.63M | +40.05M |
| 2012 | 130.58M | -407.94M |
| 2011 | 538.51M | +79.56M |
| 2010 | 458.95M | +263.62M |
| 2009 | 195.34M | +13.54M |
| 2008 | 181.80M | +22.78M |
| 2007 | 159.02M | +26.63M |
| 2006 | 132.39M | -84.44M |
| 2005 | 216.84M | +76.24M |
| 2004 | 140.59M | +47.98M |
| 2003 | 92.62M | +38.79M |
| 2002 | 53.83M | +19.84M |
| 2001 | 33.99M | +4.37M |
| 2000 | 29.62M | +1.31M |
| 1999 | 28.31M | +2.29M |
| 1998 | 26.02M | +8.88M |
| 1997 | 17.15M | +3.15M |
| 1996 | 14.00M | +0.47M |
| 1995 | 13.52M | +4.94M |
| 1994 | 8.58M |